Table 2.
OKS and predicted utility scores (EQ-5D): used to model the crossover arma
| Study Month 6b | Study Month 7b | Study Month 9b | Study Month 12b | ||
|---|---|---|---|---|---|
| OKS | Mean (SD) | 18.6 (6.6) | 30.0 (9.4) | 30.3 (10.0) | 29.8 (10.6) |
| Sample sizec | 42 | 40 | 38 | 37 | |
| SE | 1.02 | 1.49 | 1.62 | 1.74 | |
| Mapped EQ-5D | Mean (SE) | 0.377 (0.042) | 0.633 (0.043) | 0.640 (0.046) | 0.628 (0.049) |
Abbreviations: CRFA cooled radiofrequency ablation, IAS intra-articular steroid, OKS Oxford Knee Score, SD standard deviation, SE standard error
aBased on the clinical trial NCT02343003, subjects in the IAS arm were able to cross over to CRFA at study Month 6 and continued to be followed up at study Month 7, 9 and 12. Data shown for those patients in the IAS arm who received CRFA at month 6
bTime points as per clinical trial
cSample size represents only subjects who crossed over from IAS to CRFA at 6 months, with available data at each time point (based on per protocol analysis set)